Need professional-grade analysis? Visit stockanalysis.com
$1.67B
10.36
1,356
5.13%
PW Medtech Group Ltd (1358) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at HKD1.18, up 1.72% from the previous close.
Over the past year, 1358 has traded between a low of HKD0.91 and a high of HKD1.56. The stock has gained 29.2% over this period. It is currently 24.5% below its 52-week high.
PW Medtech Group Ltd has a market capitalization of $1.67B, with a price-to-earnings ratio of 10.36 and a dividend yield of 5.13%.
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines; and animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.